The #Nrose is a set of treatments using the Sectum device, Neauvia Intense Rose filler and Neauvia professional cosmeceutical care. The #Nrose treatment is a holistic treatment protocol for intimate zone rejuvenation. It consists of four sessions that revitalize the vaginal skin and significantly improve the quality of sexual life. The #Nrose can be used for women of any age who want to rejuvenate their intimate area by combining the entire holistic treatment process.
First treatment:
- firming and tightening the skin of the vulva and vaginal canal with a radiofrequency treatment of the Sectum device,
- restoring and improving the volume, firmness and shape of the vulva and hydrating the mucosa with the Intense Rose filler.
Second treatment in 3-4 sessions
Subsequent #Nrose treatment sessions are carried out 3-4 days apart and include treatments with the Sectum device. For home care, the patient is given Rejuvenation Rose Gel to topically promote skin regeneration.
Expected effects of the treatment
- Improved elasticity
- Increase in volume
- Improved aesthetics
- Increase vaginal lubrication
- Improved quality of sexual life
- Improvement in urinary incontinence
The #Nrose treatment is painless and the results can be seen after the first session. What’s more, the patient can return to daily activities immediately after the treatment! The effectiveness of #Nrose has been confirmed by clinical studies, which have observed an increase in skin tone and elasticity, including skin hydration.
Indications for treatment
- Moisturisation of the vagina.
- Overall improvement in appearance.
- Volumetric effect.
Contraindication
- Autoimmune disorders affecting the skin.
- Infections and inflammations (genital herpes, dermatitis, etc.) at or near the surgical site.
- Patients being treated with anticoagulants.
- Patients undergoing radiotherapy and ultrasound therapy in the implant area.
- Patients with known hypersensitivity to hyaluronic acid.
- Patients with a tendency to develop hypertrophic scars.
- Patient suffering from untreated epilepsy.
- Pregnant or breastfeeding women.
- Under 18 years of age.
- Patients with severe allergies.